Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

ARK Genomic Revolution ETF (NY:ARKG)

20.92 +0.10 (+0.48%)
Official Closing Price Updated: 8:00 PM EDT, May 23, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,789,413
Open 20.32
Bid (Size) 20.67 (121)
Ask (Size) 20.97 (1)
Prev. Close 20.82
Today's Range 20.26 - 20.98
52wk Range 17.50 - 31.16
Shares Outstanding 423,500
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Genetic Data From 23andMe Ends Up With This Company In $256 Million Deal
Regeneron (REGN) to acquire 23andMe for $256 million, plans to maintain consumer services and uphold privacy policies. Deal expected to close Q3 2025. 
Via Benzinga
Cathie Wood's Ark Invest Offloads Uipath, Prime Medicine, And Repare Therapeutics
On April 11th, 2025, Cathie Wood's Ark Invest sold shares in UiPath, Prime Medicine, and Repare Therapeutics, with notable gains and losses. 
Via Benzinga

Performance

YTD
-14.5%
-14.5%
1 Month
-6.6%
-6.6%
3 Month
-21.0%
-21.0%
6 Month
-16.5%
-16.5%
1 Year
-18.6%
-18.6%

More News

Read More
Cathie Wood's Ark Invest Loads Up On Robinhood, Nvidia-Backed CoreWeave: Offloads Spotify, Roku
Via Benzinga
Cathie Wood's Ark Invest Scoops Up Iridium, Beam, Pacific Biosciences While Offloading Illumina And Amgen
Via Benzinga
Cathie Wood's Big Tuesday Bet: Ark Pours $7.8 Million Into Tempus AI Despite Stock Stumble
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
Cathie Wood's Ark Invest Continues To Offload UiPath, Roblox: Loads Up On GitLab, Ibotta
Via Benzinga
Healthcare Stocks Doing Well But SMID Biotech Looking A Little Frazzled
Via Talk Markets
Topics ETFs Stocks / Equities
Cathie Wood Smelling AI Opportunity? Ark Invest Buys Tempus AI Dip, Scoops Up Over $13 M Worth Of Stock
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
Biotech Rally Coming In Weeks Ahead?
Via Talk Markets
Topics ETFs Stocks / Equities
Cathie Wood's Monday Moves: Ark Buys Tempus AI Dip And Airbnb Spike— Goes Shopping For Coinbase Stock Amid Trump Tariff Crypto Meltdown
Via Benzinga
Topics Artificial Intelligence Government
Exposures Artificial Intelligence Political
Cathie Wood's Ark Invest Loads Up On Tempus AI, Archer Aviation, But Sells Twist Bioscience: Here Are Key Ark Trades This Friday
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
Cathie Wood's Buys The Dip In Tempus AI, Coinbase But Sells Ark's Bitcoin ETF Shares Amid Crypto Meltdown
Via Benzinga
Topics Artificial Intelligence ETFs
Exposures Artificial Intelligence
Rocket Lab, Kratos, Archer Aviation And More Earnings This Week Could Have A Big Impact On Cathie Wood's Ark ETFs
Via Benzinga
Topics ETFs
Synchronicity: Denying The Unexplainable
Via Talk Markets
Topics Stocks / Equities
NIH Funding Cuts To Spook Healthcare Stocks? RFK Jr's Confirmation At HHS Sparks Concerns Over Research Dollars, 'Causing Uncertainty,' Says Analyst
Via Benzinga
Cathie Wood's Ark Invest Loads Up On Beam Therapeutics, Nu Holdings: Offloads MercadoLibre, Adaptive Biotechnologies
Via Benzinga
Biotech Stocks Had A Good Week Despite Crosscurrents
Via Talk Markets
Topics ETFs Stocks / Equities
Cathie Wood's Ark Invest Loads Up On Iridium, Twist Bioscience, Offloads Roku: Here Are Key Ark Trades This Friday
Via Benzinga
Tempus AI Executives Sell $20 Million In Stock As Cathie Wood Buys And Nancy Pelosi Eyes Options
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
Cathie Wood's Ark Invest Bets Big On Amazon, Roblox And Illumina While Trimming Palantir Stake After Alex Karp-Led Company Touched An All-Time High On Thursday
Via Benzinga
Small- To Mid-Cap Biotech Trades Poised For Gains
Via Talk Markets
Topics ETFs Stocks / Equities
Cathie Wood's Ark Invest Bets On Biotech With CRISPR Therapeutics Investment, Exits Roblox
Via Benzinga
ETFs Shine As S&P 500 Hits Record High: Top 5 ETFs With Best Gains From Last Week
Via Benzinga
Topics ETFs Economy Stocks
Exposures Economy US Equities
Intellia Stock Dips After Morgan Stanley Downgrade, Retail Sentiment Weakens
Via Stocktwits
Tempus AI Stock Eyes Best Rally In 5 Months Amid Pelosi-Linked Hype, But Retail’s Turning Doubtful Now
Via Stocktwits
Topics Artificial Intelligence
Exposures Artificial Intelligence

Frequently Asked Questions

Is ARK Genomic Revolution ETF publicly traded?
Yes, ARK Genomic Revolution ETF is publicly traded.
What exchange does ARK Genomic Revolution ETF trade on?
ARK Genomic Revolution ETF trades on the New York Stock Exchange
What is the ticker symbol for ARK Genomic Revolution ETF?
The ticker symbol for ARK Genomic Revolution ETF is ARKG on the New York Stock Exchange
What is the current price of ARK Genomic Revolution ETF?
The current price of ARK Genomic Revolution ETF is 20.92
When was ARK Genomic Revolution ETF last traded?
The last trade of ARK Genomic Revolution ETF was at 05/23/25 08:00 PM ET
What is the market capitalization of ARK Genomic Revolution ETF?
The market capitalization of ARK Genomic Revolution ETF is 8.86M
How many shares of ARK Genomic Revolution ETF are outstanding?
ARK Genomic Revolution ETF has 9M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.